Prediction of outcome in the treatment of onychomycosis

Clinical and Experimental Dermatology

Volumn 28, Issue 4, 2003, Pages 425-428

  Sommer, S ^a   Sheehan Dare, R A ^a   Goodfield, M J D ^a,b   Evans, E G V ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TERBINAFINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHYTE; DERMATOPHYTOMA; DRUG RESPONSE; FEMALE; GROWTH; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; MALE; MULTICENTER STUDY; NAIL; ONYCHOLYSIS; ONYCHOMYCOSIS; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIFUNGAL AGENTS; FEMALE; FOOT DERMATOSES; HUMANS; KERATOSIS; MALE; MIDDLE AGED; NAPHTHALENES; ONYCHOMYCOSIS; PHOTOGRAPHY; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 0038045488     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2003.01308.x     Document Type: Article

References (14)

1. Korting HC, Schafer-Korting M. Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin. Arch Dermatol 1992; 128: 243-8.
2. Evans EGV, Sigurgeirsson B for the LION Study Group. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. Br Med J 1999; 318: 1031-5.
3. Epstein E. How often does oral treatment of toenail onychomycosis produce a disease free nail? Arch Dermatol 1998; 134: 1551-4.
4. Sigurgeisson B, Curran D, Evans EG. Prognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agents. Br J Dermatol 2002; 147: 1241-3.
5. Baran R, De Doncker P. Lateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals. Acta Derm Venereol (Stockh) 1996; 576: 82-3.
6. Roberts DT, Evans EGV. Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol 1998; 138: 189-90.
7. Baran R, Hay RJ, Tosti A, Haneke EH. A new classification of onychomycosis. Br J Dermatol 1998; 139: 567-71.
8. Scher RK. Onychomycosis: therapeutic update. J Am Acad Dermatol 1999; 40: S21-6.
9. Zaias N, Tosti A, Regell G et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol 1996; 37: 302-4.
10. Haneke E. Nagelveränderungen bei Erkrankungen des Endokriniums. Therapiewoche 1987; 37: 4379-82.
11. Haneke E. Epidemiology and pathology of onychomycosis. In: Nolting, S, Korting, HC, eds. Onychomycoses Berlin: Springer-Verlag 1989, 1-8.
12. Hay RJ, Roberts SOB, Mackenzie DWR. Mycology. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology, 5th edn, Vol. 2. Oxford: Blackwell Scientific Publications, 1992: 1158-9.
13. Goulden V, Goodfield MJD. Onychomycosis and linear nail growth. Br J Dermatol 1997; 136: 132-48.
14. Shuster IJ. Practical Handbook of Sample Size Guidelines for Clinical Trials. Boca Raton: CRC Press, 1993.